Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

with the resignations of Con Flannigan & Robert Trapp

how does this affect the 'BOD Responsibilities' of the 4/5/17 LOI Update:

http://www.amarantus.com/news/press-releases/detail/2064/amarantus-provides-update-on-restructuring-efforts-and

THE RESTRUCTURING OF AMARANTUS

In connection with the LOI, SeD Biomedical was entitled to appoint four new directors to the Board of Directors of Amarantus (the "Board"). These new directors, who commenced their service as members of the Board on February 23, 2017, have a strong track record of restructuring distressed companies, and plan on working with Amarantus' management to attempt to build new value for Amarantus' shareholders. The Board is presently working with management to evaluate the operations and financial structure of Amarantus, with a goal of restructuring Amarantus. The Board is also evaluating Amarantus' intellectual property, with a goal of determining strategic priorities, including which of Amarantus' intellectual property may be maintained for future projects, and which may be sold, cancelled or spun off into new entities. Upon the completion of the Board's review and formulation of a plan, the Board shall task management with engaging in discussions with creditors regarding the implementation of such plan for debt restructuring and potential reorganization.